Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(15%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
1
8%
Ph phase_2
2
15%
Ph not_applicable
10
77%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
2(15.4%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(5)
Terminated(1)
Other(4)

Detailed Status

Completed5
unknown4
Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (7.7%)
Phase 22 (15.4%)
N/A10 (76.9%)

Trials by Status

not_yet_recruiting18%
unknown431%
recruiting215%
terminated18%
completed538%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DEVICE
Total Trials
13